Insulin-like growth factors and cancer

Lancet Oncology

Volumn 3, Issue 5, 2002, Pages 298-302

  Fürstenberger, Gregor ^a   Senn, Hans Jörg ^a  

^a Tumor Center ZeTuP   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CAROTENOID; COLECALCIFEROL DERIVATIVE; GROWTH HORMONE; LYCOPENE; PROTEIN P53; RETINOIC ACID DERIVATIVE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SURAMIN; TAMOXIFEN;

APOPTOSIS; BLOOD LEVEL; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LUNG CANCER; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036111682     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(02)00731-3     Document Type: Review

References (62)

1. Circulating concentrations of insulin-like growth factor 1 and risk of breast cancer
2. Insulin-like growth factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer
3. Plasma Insulin-like growth factor-I (IGF-I) concentrations in human breast cancer
4. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
5. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
6. Insulin-like growth factor 1 and prostate cancer risk: A population-based, case-control study
7. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
8. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
9. Colon cancer and polyps in acromegaly: Increased risk associated with family history of colon cancer
10. Acromegaly and gastrointestinal cancer
11. Acromegaly, colonic polyps and carcinoma
12. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
13. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control study
14. A prospective study of insulin-like growth factor-I, IGF-binding-proteins-1,-2, and -3 and lung cancer risk in women
15. Metabolic effects of IGFs
16. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
17. Structure and function of the insulin-like growth factor I receptor
18. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumour suppressor gene
19. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
20. Insulin-like growth factor binding proteins and their role in controlling IGF actions
21. The role of insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action
22. Role of the insulin-like growth factor family in cancer development and progression
23. New concepts in regulation and function of the insulin-like growth factors: Implications for understanding normal growth and neoplasia
24. Role of Insulin-Like Growth Factors and Their Binding Proteins in Growth Control and Carcinogenesis
25. The effect of insulin-like growth factors on tumorigenesis and neoplastic growth
26. Insulin-like growth factor I and prostate cancer
27. Insulin-like growth factor I and prostate cancer: A meta-analysis
28. Insulin, insulin-like growth factors and colon cancer: A review of the evidence
29. The IGF/IGFBP system in CNS malignancy
30. The IGF axis and hepatocarcinogenesis
31. The IGF system in thyroid cancer: New concepts
32. Metabolic effects of IGFs
33. IGF-I receptor signalling in transformation and differentiation
34. The role of insulin-like growth factor system in human cancer
35. The role of IGF-I receptor in the growth and transformation of mammalian cells
36. The insulin-like growth factor I receptor: A key to tumour growth?
37. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor receptor gene
38. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts
39. Simian virus 40 large tumour antigen is unable to transform mouse embryonic fibroblasts lacking type I insulin-like growth factor receptor
40. c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines
41. Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells
42. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors
43. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis
44. Cooperative transformation of 32 D cells by the combined expression of IRS-1 and v-Ha-Ras
45. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
46. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer
47. Insulin-like binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in breast cancer cells
48. Signalling pathways involved in antiproliferative effects of IGFBP-3: A review
49. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumour cells
50. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
51. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients
52. Influence of treatment with tamoxifen and change in tumour burden on the IGF-system in breast cancer patients
53. Evaluation of continuous infusion suramin in metastatic breast cancer impact on plasma levels of insulin-like growth factors (IGFs) and IGF binding proteins
54. Suramin decreases circulating levels of insulin-like growth factor-I
55. Vitamin D analogues suppress IGF-I singnalling and promote apoptosis in breast cancer cells
56. Lycopene interferes with cell cycle progression and insulin like growth factor I signalling in mammary breast cancer cells
57. Long-term effect of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in woman with early breast cancer
58. Randomized trial of fenretinide to prevent second breast malignancy in woman with early breast cancer
59. Results of a pilot study involving the use of an antisense oligodeoxy-nucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas
60. Single-chain antibodies against human insulin like growth factor I receptor: Expression, purification, and effect on tumour growth
61. Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice
62. Inhibition of insulin-like growth factor I receptor increases the antitumour activity of doxorubicine and vincristine against Ewing sarcoma cells